Our finding that AMPK inhibition abolishes the RAF inhibitor–driven paradoxical activation of RAF–MEK–ERK signaling in Ras-mutated cancer cells and thus inhibits their overgrowth provides a potential combination therapy to control Ras mutation–driven cancers. Here, MAP2K7 is linked to cancer.